Scott W. Morrison
CIK: 0001662426
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (17 total)
- Jun 25, 2026TARS
Tarsus Pharmaceuticals, Inc.
Award(A)DirectStock Option (right to buy)
3.8K shares- - Jun 25, 2026TARS
Tarsus Pharmaceuticals, Inc.
Award(A)DirectRestricted Stock Units
2.4K shares- - Jun 17, 2026ZLAB
Zai Lab Ltd
Award(A)Direct22.4K shares- - Jun 16, 2026IDYA
IDEAYA Biosciences, Inc.
Award(A)DirectStock Option (right to buy)
20K shares- - Jun 12, 2026TARS
Tarsus Pharmaceuticals, Inc.
Exercise(M)Direct3K shares- - May 21, 2026VERA
Vera Therapeutics, Inc.
Award(A)DirectStock Option (right to buy)
17.1K shares- - Sep 15, 2025TARS
Tarsus Pharmaceuticals, Inc.
Exercise(M)Direct1.3K shares- - Jun 24, 2025IDYA
IDEAYA Biosciences, Inc.
Award(A)DirectStock Option (right to buy)
20K shares- - Jun 18, 2025ZLAB
Zai Lab Ltd
Award(A)Direct10.8K shares- - Jun 13, 2025TARS
Tarsus Pharmaceuticals, Inc.
Exercise(M)Direct3.4K shares- - Jun 12, 2025CRVS
Corvus Pharmaceuticals, Inc.
Award(A)DirectStock Option (Right to Buy)
15K shares- - Jun 12, 2025TARS
Tarsus Pharmaceuticals, Inc.
Award(A)DirectRestricted Stock Units
3K shares- - Jun 12, 2025TARS
Tarsus Pharmaceuticals, Inc.
Award(A)DirectStock Option (right to buy)
4.5K shares- - May 14, 2025VERA
Vera Therapeutics, Inc.
Award(A)DirectStock Option (right to buy)
14K shares- - May 9, 2025ZLAB
Zai Lab Ltd
Sale(S)Direct23.8K shares at avg. $30.05$715K - Sep 30, 2024TARS
Tarsus Pharmaceuticals, Inc.
Gift(G)Direct6K shares- - Sep 15, 2024TARS
Tarsus Pharmaceuticals, Inc.
Exercise(M)Direct1.3K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 25, 2026 |  TARS Tarsus Pharmaceuticals, Inc. | Award(A) Stock Option (right to buy) | 3,837 | - | - | Direct |
| Jun 25, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Award(A) Restricted Stock Units | 2,417 | - | - | Direct |
| Jun 17, 2026 |  ZLAB Zai Lab Ltd | Award(A) | 22,371 | - | $0 | Direct |
| Jun 16, 2026 |  IDYA IDEAYA Biosciences, Inc. | Award(A) Stock Option (right to buy) | 20,000 | - | - | Direct |
| Jun 12, 2026 | TARS Tarsus Pharmaceuticals, Inc. | Exercise(M) | 2,954 | - | $0 | Direct |
| May 21, 2026 |  VERA Vera Therapeutics, Inc. | Award(A) Stock Option (right to buy) | 17,084 | - | - | Direct |
| Sep 15, 2025 | TARS Tarsus Pharmaceuticals, Inc. | Exercise(M) | 1,334 | - | - | Direct |
| Jun 24, 2025 | IDYA IDEAYA Biosciences, Inc. | Award(A) Stock Option (right to buy) | 20,000 | - | - | Direct |
| Jun 18, 2025 | ZLAB Zai Lab Ltd | Award(A) | 10,831 | - | - | Direct |
| Jun 13, 2025 | TARS Tarsus Pharmaceuticals, Inc. | Exercise(M) | 3,350 | - | - | Direct |
| Jun 12, 2025 |  CRVS Corvus Pharmaceuticals, Inc. | Award(A) Stock Option (Right to Buy) | 15,000 | - | - | Direct |
| Jun 12, 2025 | TARS Tarsus Pharmaceuticals, Inc. | Award(A) Restricted Stock Units | 2,954 | - | - | Direct |
| Jun 12, 2025 | TARS Tarsus Pharmaceuticals, Inc. | Award(A) Stock Option (right to buy) | 4,540 | - | - | Direct |
| May 14, 2025 | VERA Vera Therapeutics, Inc. | Award(A) Stock Option (right to buy) | 14,000 | - | - | Direct |
| May 9, 2025 | ZLAB Zai Lab Ltd | Sale(S) | 23,799 | $30.05 | $715,086 | Direct |
| Sep 30, 2024 | TARS Tarsus Pharmaceuticals, Inc. | Gift(G) | 6,016 | - | $0 | Direct |
| Sep 15, 2024 | TARS Tarsus Pharmaceuticals, Inc. | Exercise(M) | 1,333 | - | $0 | Direct |
1-17 of 17 transactions
About Morrison Scott W
Morrison Scott W (SEC CIK 0001662426) files insider reports with the SEC as Director of Tarsus Pharmaceuticals, Inc. (TARS), Director of Zai Lab Ltd (ZLAB) and Director of IDEAYA Biosciences, Inc. (IDYA). Signal8 also holds filings tied to 2 other companies.
Signal8 holds 14 ownership filings by Morrison Scott W, all Form 4s, filed between Sep 17, 2024 and Jun 29, 2026. Those filings report 17 transactions, from Sep 15, 2024 to Jun 25, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Morrison Scott W's filings is in IRVINE, CA.
Recent filings by Morrison Scott W
- Jun 25, 2026: Grants or awards of TARS derivative securities (2 lines, Form 4, code A).
- Jun 17, 2026: Grant or award of ZLAB shares (Form 4, code A).
- Jun 16, 2026: Grant or award of IDYA derivative securities (Form 4, code A).
- Jun 12, 2026: Option exercise of TARS shares (Form 4, code M).
- May 21, 2026: Grant or award of VERA derivative securities (Form 4, code A).
Other insiders filing for Tarsus Pharmaceuticals, Inc. (TARS)
- PYOTT DAVID E I, Director
- YARNO WENDY L, Director
- LINK WILLIAM J PHD, Director
- Azamian Bobak R., President/CEO and Board Chair
- Lin Elizabeth Yeu, Chief Medical Officer
- Neervannan Seshadri, Chief Operating Officer